Skip to main content
Carelabs Co.,Ltd logo

Carelabs Co.,Ltd — Investor Relations & Filings

Ticker · 263700 ISIN · KR7263700007 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 455 across all filing types
Latest filing 2022-03-11 AGM Information
Country KR South Korea
Listing KO 263700

About Carelabs Co.,Ltd

https://www.carelabs.co.kr/

Carelabs Co., Ltd. is a platform company that provides comprehensive IT services for the healthcare and beauty care sectors. The company develops and operates solutions aimed at creating a more convenient and accessible healthcare ecosystem by resolving imbalances in medical information. Its core services include specialized customer relationship management (CRM) software for hospitals, such as 'SmartCRM' and 'UnoCRM', which support patient management and marketing activities. Additionally, Carelabs offers performance-based digital marketing services tailored to clients in the medical field. Through its technology-driven platforms, the company facilitates online-to-offline (O2O) connections within the health and beauty markets.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Carelabs, dated March 11, 2022. It outlines the meeting agenda, including financial statement approval, director/auditor appointments, and remuneration limits. It also contains detailed management information, such as board activity reports and business overviews, which are standard components of proxy materials sent to shareholders to solicit votes for an upcoming meeting. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2022-03-11 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Carelabs. It outlines the date, location, and agenda items (such as financial statement approval, director/auditor appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items, fitting the definition of Proxy Solicitation & Information Statement (PSI).
2022-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Carelabs) announcing a significant change (over 15-30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (DART system) for material financial changes. Since it provides key financial highlights and reasons for the variance rather than being a full annual report or a simple announcement of a report's availability, it falls under the category of a general regulatory filing. FY 2021
2022-02-25 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status under Trust Agreement' (신탁계약등에의한취득상황보고서) filed by Carelabs Co., Ltd. to the Financial Supervisory Service (FSS). It details the company's purchase of its own shares through a trust contract with NH Investment & Securities. This type of filing is a specific regulatory requirement in South Korea for companies executing share buybacks via trust agreements, which falls under the category of 'Transaction in Own Shares'.
2022-01-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in Korea. This type of regulatory filing is used to disclose when an entity's shareholding in a company crosses a specific threshold (in this case, 5%). According to the provided filing definitions, this falls under 'Major Shareholding Notification' (MRQ).
2022-01-10 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Carelabs regarding the 'Exercise of Conversion Rights' (전환청구권행사) for convertible bonds. It details the number of shares issued, the conversion price, and the remaining balance of convertible bonds. This type of corporate action, involving the conversion of debt into equity, falls under capital structure changes and share issuance, which is best classified as 'Share Issue/Capital Change' (SHA).
2022-01-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.